Jon Cuthbert

Solana DeFi projects are facing heightened scrutiny after a $285 million exploit of the Drift protocol was linked to a North Korean state-affiliated group.

Changpeng Zhao, founder of Binance, has released a memoir recounting the exchange’s rapid rise and the legal challenges that led to his prison sentence.

MYOB and Microsoft (NASDAQ:MSFT) launch a five-year AI partnership to bring agentic automation and "Powered by Microsoft" tools to SMEs across ANZ.

Marsh McLennan Agency, a subsidiary of Marsh (NYSE:MRSH), announced on April 7, 2026, the acquisition of Seitz Insurance Agency, a prominent independent firm based in Sidney, Montana, specializing in high-growth regional sectors.

AuCyber (ASX:CYB) announced a leadership transition, confirming a change in its CFO position effective April 7.

Jaguar Health (NASDAQ:JAGX), a commercial-stage pharmaceutical company focused on gastrointestinal products, released its consolidated financial results for the fourth quarter and full year ended December 31, 2025, on April 7, 2026.

Booz Allen Hamilton (NYSE:BAH) announced on April 7, 2026, the successful completion of its acquisition of Defy Security, a move aimed at consolidating its position as a dominant provider of high-speed, tech-enabled cybersecurity services for both commercial and government sectors.

Artivion (NYSE:AORT), a leading cardiac and vascular surgery company, announced on April 7, 2026, that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the NEXUS™ Aortic Arch System.

Ascendis Pharma (NASDAQ:ASND) has officially commenced the commercial launch of YUVIWEL® (navepegritide) in the United States, marking the availability of the first once-weekly treatment for pediatric patients with achondroplasia.

Telix Pharmaceuticals (NASDAQ:TLX), a global leader in radiopharmaceutical precision medicine, has reported Q1 2026 group revenue of $230 million, representing a 24% increase over the same period last year and an 11% sequential rise from the previous quarter.